nav Searchuser
Maxunitech Inc.
Beijing Multigrass Formulation Co., Ltd.

Bayer faces U.S. antitrust hurdles for Monsanto mergerqrcode

Mar. 16, 2018

Favorites Print
Forward
Mar. 16, 2018
Bayer faces continued U.S. antitrust objections over its planned takeover of Monsanto, as officials fears the merger would hurt competition, according to two people familiar with the matter.

The Justice Department's antitrust division doesn't think Bayer's proposal to sell businesses goes far enough, said the people. The government wants the German chemicals company to divest more assets to resolve its concerns, said one of the people, who asked not to be named because the investigation is confidential.

Negotiations between the two sides are continuing and a final decision by the government is probably months away, the person said. Talks have been constructive as Bayer has taken steps to address the government's concerns, the person added.

Monsanto shares tumbled 4% to 118.18 on the stock market today, after briefly hitting 116.29. Bayer's U.S. shares sank 1.5%. Representatives for Bayer, Monsanto and the Justice Department declined to comment.

Bayer's $66 billion takeover of St. Louis-based Monsanto is part of a wave of consolidation that has swept seed and crop-chemical firms. The companies are seeking approval from U.S. and European officials after two previous deals — the combination of Dow Chemical and DuPont, now DowDuPont — and China National Chemical Corp.'s takeover of Syngenta — won antitrust clearance.
Source: Bloomberg

Picture 0/1200

More from AgroNews

Sichuan Lomon Bio Technology Co., Ltd.

Magazine

2019 Formulation & Adjuvant Technology Annual Review 2018
Chinese issue of Annual Review 2018 Chinese issue of 2018 Market Insight
2018 Market Insight Chinese issue of 2018 CRO & CRAO Manual
I wanna post a press Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

Picture 0/1200

Subscribe to daily email alerts of AgroNews.